Safer supply programs are a novel response to the ongoing overdose crisis in Canada--providing people at high overdose risk with a safer alternative to the highly toxic unregulated drug supply. The MySafe program provides pharmaceutical-grade opioids to participants via biometric dispensing machines. This study examines program-related goals and related outcomes across time.
No takes yet. Share an insight, caveat, or question.
Ivsins et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: